Distal radius fractures, commonly known as wrist fractures, are among the most frequent injuries seen in emergency departments. These injuries often require a closed reduction, a procedure in which the broken bone is manipulated back into place without surgery. One of the main challenges during this procedure is providing adequate pain control.

Traditionally, many hospitals use a "hematoma block," which means injecting a local anesthetic directly into the site of the fracture. This technique is simple and generally safe, but it does not always provide enough pain relief. Some patients continue to experience significant discomfort, especially in the fingers, during the traction and manipulation required to realign the bone.

Another option is to block the median nerve at the wrist. The median nerve supplies sensation to the thumb, index, and middle fingers. When combined with a hematoma block, this technique may improve digital pain relief during fracture reduction. However, this combined approach has not been well studied in Spain, and there is limited high-quality evidence worldwide.

The purpose of this study is to compare two methods of pain control during closed reduction of displaced distal radius fractures in adults: Hematoma block alone versus Hematoma block combined with median nerve block.

We hypothesize that the combined approach will reduce pain more effectively than the hematoma block alone.

The study is designed as a prospective, multicenter, randomized clinical trial involving 112 adult patients treated at two hospitals in Madrid (Hospital Universitario 12 de Octubre and Hospital Universitario de Getafe). Eligible participants are adults aged 18 to 100 years with an acute distal radius fracture (less than 48 hours old) requiring closed reduction. Patients will be randomly assigned to one of the two treatment groups.

Pain will be assessed using a Visual Analog Scale (VAS) at three key moments: during finger traction, during the reduction itself, and at hospital discharge (90-120 minutes after casting). Other information such as age, sex, fracture side, and prior use of pain or psychiatric medication will also be collected.

By answering whether the addition of a median nerve block improves pain control, this study could help establish a new protocol for managing distal radius fractures. If effective, this approach may lead to greater comfort for patients, higher satisfaction, and better overall outcomes in emergency care.

Inclusion Criteria:

• Adults aged 18 to 100 years.
• Diagnosis of acute displaced distal radius fracture (< 48 hours since injury).
• Indication for closed reduction and immobilization.
• Ability to provide informed consent.

Exclusion Criteria:

• Age under 18 years or open physes on plain radiograph.
• Open or pathological distal radius fractures.
• Local infection at or near the planned injection site.
• Significant neurological disease or cognitive impairment interfering with study participation.
• Presence of osteosynthesis material in the same segment of the affected limb.
• Known allergy or contraindication to local anesthetics used in the study.

De-identified individual participant data (IPD) collected during the trial that underlie the primary and secondary outcomes will be shared. This includes pain scores (VAS values), demographic information (age, sex, fracture side, prior medication use), and adverse event data. No information that could directly identify a participant (e.g., names, dates of birth, hospital ID numbers) will be included. Requests should be directed to the Principal Investigator (jaguerrero14@hotmail.com)

IPD Sharing Start Date:

Approximately 6 months after publication of the primary study results (end-2026).

IPD Sharing End Date:

Data will be available for 5 years after publication (end-2031).

Who will be able to access the IPD and supporting information:

Qualified researchers with a methodologically sound proposal will be able to access the data. Access will be considered for investigators affiliated with academic institutions or healthcare organizations who intend to use the data for research aligned with the aims of this study.

What they will be able to access:

De-identified individual participant data underlying the primary and secondary outcomes (VAS pain scores, demographics, adverse event data), as well as the study protocol, statistical analysis plan, and data dictionary.

How they will be able to access it:

Researchers may request access by contacting the Principal Investigator. Following approval of the proposal by the study investigators, the dataset and supporting documents will be transferred using secure, encrypted methods to protect confidentiality.